Physician profile
John Galant
NPI 1356454078
$7,211.94
in general payments reported to CMS, 2019-2025
27 companies · $1,965 in 2025
The $1,965 reported for 2025 was more than what 90% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $263 · 2021: $97.42 · 2022: $768 · 2023: $779 · 2024: $2,328 · 2025: $1,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,704 · Long Term Medical Supply Or Device Loan: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,703.53 |
| Long Term Medical Supply Or Device Loan | $368.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,595.14 | 2019-2025 | Citrefix, Infinity Adaptis, Infinity |
| Smith+Nephew, INC. | $728.79 | 2019-2025 | Oasis, Grafix Pl, Stravix Pl |
| Treace Medical Concepts, INC. | $540.68 | 2022-2025 | |
| Integra Lifesciences Corporation | $486.48 | 2023-2024 | Acell, Integra, Primatrix |
| Paratek Pharmaceuticals, INC. | $485.87 | 2023-2025 | Nuzyra |
| Amgen INC. | $425.57 | 2024-2025 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $271.34 | 2019-2022 | |
| Royal Biologics, INC. | $248.98 | 2020-2022 | |
| Organogenesis INC. | $220.63 | 2019-2020 | |
| Paragon 28, INC. | $218.29 | 2022-2025 | Hammertube Sterile Implant Kits, Paratrooper |
| Abbott Laboratories | $216.57 | 2019-2023 | Proclaim |
| Tactile Systems Technology INC | $212.99 | 2025 | Nimbl, Flexitouch Plus |
| Kerecis Limited | $187.59 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Next Science LLC | $174.70 | 2024 | Xperience, Surgx, Blastx |
| Convatec INC. | $154.31 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $151.34 | 2022-2023 | |
| Extremity Medical | $146.88 | 2025 | |
| Biocomposites INC | $143.18 | 2025 | Stimulan |
| Osiris Therapeutics INC. | $122.28 | 2019 | |
| Grt US Holding, INC. | $120.82 | 2022 | |
| Urgo Medical North America, LLC | $117.94 | 2023 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $97.42 | 2021 | |
| Crossroads Extremity Systems, LLC | $68.43 | 2019 | |
| Baxter Healthcare | $25.70 | 2019 | |
| Wright Medical Technology, INC. | $20.18 | 2019 | |
| Avanos Medical | $15.33 | 2019 | |
| Sebela Pharmaceuticals INC. | $14.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Galant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.